1. Home
  2. LGL vs CELU Comparison

LGL vs CELU Comparison

Compare LGL & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • CELU
  • Stock Information
  • Founded
  • LGL 1917
  • CELU 2016
  • Country
  • LGL United States
  • CELU United States
  • Employees
  • LGL N/A
  • CELU N/A
  • Industry
  • LGL Industrial Machinery/Components
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGL Technology
  • CELU Health Care
  • Exchange
  • LGL Nasdaq
  • CELU Nasdaq
  • Market Cap
  • LGL 38.5M
  • CELU 42.2M
  • IPO Year
  • LGL N/A
  • CELU N/A
  • Fundamental
  • Price
  • LGL $7.51
  • CELU $2.96
  • Analyst Decision
  • LGL
  • CELU
  • Analyst Count
  • LGL 0
  • CELU 0
  • Target Price
  • LGL N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • LGL 13.7K
  • CELU 578.5K
  • Earning Date
  • LGL 08-12-2025
  • CELU 05-08-2025
  • Dividend Yield
  • LGL N/A
  • CELU N/A
  • EPS Growth
  • LGL 204.51
  • CELU N/A
  • EPS
  • LGL 0.08
  • CELU N/A
  • Revenue
  • LGL $4,322,000.00
  • CELU $54,220,000.00
  • Revenue This Year
  • LGL N/A
  • CELU $23.29
  • Revenue Next Year
  • LGL N/A
  • CELU N/A
  • P/E Ratio
  • LGL $99.26
  • CELU N/A
  • Revenue Growth
  • LGL 20.66
  • CELU 138.11
  • 52 Week Low
  • LGL $5.03
  • CELU $1.00
  • 52 Week High
  • LGL $9.74
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • LGL 54.93
  • CELU 58.85
  • Support Level
  • LGL $7.52
  • CELU $2.01
  • Resistance Level
  • LGL $7.77
  • CELU $4.35
  • Average True Range (ATR)
  • LGL 0.19
  • CELU 0.38
  • MACD
  • LGL -0.02
  • CELU 0.10
  • Stochastic Oscillator
  • LGL 53.33
  • CELU 44.62

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: